In-office Evaluation of Two Toric Soft Contact Lenses and a Spherical Soft Contact Lens
- Conditions
- Astigmatism
- Interventions
- Device: senofilcon A toric contact lensDevice: alphafilcon A toricDevice: etafilcon A sphere
- Registration Number
- NCT00584727
- Lead Sponsor
- Johnson & Johnson Vision Care, Inc.
- Brief Summary
The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric and a spherical contact lens currently available in market, specifically with regards to the fit and visual acuity as well as the comfort, vision and satisfaction while in the practitioner's office. Approximately 2 hours duration.
- Detailed Description
Non-dispensing, single-masked (subject-masked), randomised, controlled study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 96
- be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
- be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy
- have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
- be able and willing to adhere to the instructions set forth in the protocol.
- agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
- have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
- have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
- be in good general health, based on his/her knowledge.
- read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
-
The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
-
The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
-
The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
-
Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium or corneal scars within the visual axis
- Neovascularization >1mm in from the limbus
- History of giant papillary conjunctivitis (GPC) worse than Grade 2
- Anterior uveitis or iritis (past or present)
- Seborrhoeic eczema, seborrhoeic conjunctivitis
-
A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
-
A known history of corneal hypoesthesia (reduced corneal sensitivity.)
-
Aphakia, keratoconus or a highly irregular cornea.
-
Current pregnancy or lactation (to the best of the subject's knowledge).
-
Active participation in another clinical study at any time during this study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description senofilcon A/alphafilcon A/etafilcon A alphafilcon A toric First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses alphafilcon A/etafilcon A/senofilcon A alphafilcon A toric First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses alphafilcon A/etafilcon A/senofilcon A etafilcon A sphere First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses etafilcon A/senofilcon A/alphafilcon A etafilcon A sphere First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses senofilcon A/etafilcon A/alphafilcon A senofilcon A toric contact lens First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses senofilcon A/alphafilcon A/etafilcon A senofilcon A toric contact lens First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses senofilcon A/alphafilcon A/etafilcon A etafilcon A sphere First intervention:senofilcon A toric contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses etafilcon A/senofilcon A/alphafilcon A alphafilcon A toric First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses alphafilcon A/etafilcon A/senofilcon A senofilcon A toric contact lens First intervention: alphafilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: senofilcon A toric contact lenses senofilcon A/etafilcon A/alphafilcon A alphafilcon A toric First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses etafilcon A/alphafilcon A/senofilcon A senofilcon A toric contact lens First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses etafilcon A/alphafilcon A/senofilcon A alphafilcon A toric First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses etafilcon A/senofilcon A/alphafilcon A senofilcon A toric contact lens First intervention: etafilcon A sphere contact lenses Second intervention:senofilcon A toric contact lenses Third intervention: alphafilcon A toric contact lenses senofilcon A/etafilcon A/alphafilcon A etafilcon A sphere First intervention: senofilcon A toric contact lenses Second intervention: etafilcon A sphere contact lenses Third intervention: alphafilcon A toric contact lenses alphafilcon A/senofilcon A/etafilcon A senofilcon A toric contact lens First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses alphafilcon A/senofilcon A/etafilcon A alphafilcon A toric First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses alphafilcon A/senofilcon A/etafilcon A etafilcon A sphere First intervention: alphafilcon A toric contact lenses Second intervention: senofilcon A toric contact lenses Third intervention: etafilcon A sphere contact lenses etafilcon A/alphafilcon A/senofilcon A etafilcon A sphere First intervention: etafilcon A sphere contact lenses Second intervention: alphafilcon A toric contact lenses Third intervention: senofilcon A toric contact lenses
- Primary Outcome Measures
Name Time Method Visual Acuity 15-20 minutes Number of eyes with Distance Visual Acuity 20/20 or better
Lens Stability Within 5 Degrees 1 minute Measures if the lens changes position on the eye as it is worn and is measured in degrees of rotation.
Patient Reported Vision 15-20 minutes A weighted combined score calculated from individual confort-vision related questions asked on a 1-5 scale, 1=most negative resonse to 5=most positive response, was used to derive vision scores. The analysis shows the difference in outcome between test and control. \>0=greater vision, \<0=lesser vision.
Lens Orientation Within 5 Degrees 1 minute Meaures in what position does the lens sit on the eye at insertion and is measured in degrees of rotation.
Patient Reported Comfort. 15-20 minutes A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. \>0=comfortable, \<0=uncomfortable
Patient Preference end of study This outcome measures which lens the subjects preferred to wear.
- Secondary Outcome Measures
Name Time Method